1. All Products
  2. D - Drugs
  3. SP 1x250/12.5mg+ AQ 3xeq.75-76.5mg base,cobl.disp.tb,4.5-8kg
Public Pricelist

SP 1x250/12.5mg+ AQ 3xeq.75-76.5mg base,cobl.disp.tb,4.5-8kg

https://medicalguidelines.msf.org/en/node/634
https://unicat.msf.org/cat/product/65941
STD DORASPAQ1TD2

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.5.3.2 - For chemoprevention
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BD51
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

SULFADOXINE/PYRIMETHAMINE (SP) + AMODIAQUINE (AQ)

Therapeutic Action

Co-blister of three antimalarials: sulfadoxine/pyrimethamine and amodiaquine tablets combined in the same blister pack.

Indications

Seasonal malaria chemoprevention in children

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Dispersible tablets intended for paediatric use.

Two different presentations for 2 categories of weight:

  • infants: 2-11 months, 4.5-8 kg
  • toddlers: 1-5 years old, 9-17 kg

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Storage

Below 25°C ‐ Protect from sunlight